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The realization that there existed a G-protein coupled signal transduction mechanism developed gradually and was initially the result of an ill
fated quest for uncovering the mechanism of action of insulin, followed by a refocused research in many laboratories, including mine, on how
GTP acted to increase hormonal stimulation of adenylyl cyclase. Independent research into how light-activated rhodopsin triggers a response in
photoreceptor cells of the retina and the attendant biochemical studies joined midway and, without the left hand knowing well what the right hand
was doing, preceded classical G protein research in identifying the molecular players responsible for signal transduction by G proteins.
© 2006 Elsevier B.V. All rights reserved.
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Although I participated in expanding the field of transmem-
brane signaling during my whole scientific career, my major
contributions happened at the beginning, during the mechanism⁎ Tel.: +1 919 541 3205; fax: +1 919 541 4214.
E-mail address: birnbau1@niehs.nih.gov.
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doi:10.1016/j.bbamem.2006.09.027of action of insulin phase. It focused on hormonal activation of
adenylyl cyclase and led to the demonstration that receptors are
separate molecules from the adenylyl cyclase proper – then
called adenyl cyclase – that adenylyl cyclase-activating
receptors acted through a transduction mechanism involving
changes in adenylyl cyclase's sensitivity to ambient Mg2+, and
that there existed a role for GTP in the activation of the liver
enzyme by glucagon, the binding of which was also changed by
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protein coupled receptor – GPCR – to be identified on the basis
of changing behavior upon addition of GTP, even though at that
time the G-protein as the site of action of the GTP, was still
unknown. What became the G protein was first conceptualized
as a transducing function – referred to as transducer – that could
or could not be executed by a molecule separate from receptor
and adenylyl cyclase.
2. It all began in Martin Rodbell’s laboratory
My role began the day Martin Rodbell took me from his
home to his laboratory in Building 10 of the NIH Campus in
Bethesda. I had arrived the evening before from Argentina with
a brand new PhD degree in Biochemistry, and Marty – as we all
called him – had offered me to stay in his house until I found
housing of my liking. I had come to Rodbell's laboratory
because he had recently published work on the isolation of free
fat cells and their exquisite sensitivity to insulin, including that
of insulin's effect to antagonize the lipolytic actions of catabolic
hormones such as epinephrine, glucagon and adrenocortico-
tropin, ACTH. Sutherland's group had shown that these
hormones induce lipolysis using cAMP as a second messenger
(a discovery for which he was to receive the 1971 Nobel Prize in
Medicine), and that in adipose tissue, insulin reduced the levels
of cAMP that had been elevated by lipolytic hormones (shown
for epinephrine in Fig. 1 — adapted from Butcher et al., 1966
[1]). It was Rodbell's hypothesis that insulin antagonized
lipolysis by inhibiting the adenylyl cyclase, and this would be
my project in his laboratory. Knowing that I would have to
measure adenylyl cyclase I had, before leaving Argentina, set up
the assay used by Sutherland's group to quantify cAMP. This
assay used an enzymatic reaction cascade in which the cAMP
formed by the enzyme stimulated phosphorylase-b-kinase
kinase, the activated phosphorylase-b-kinase phosphorylated
muscle phosphorylase b and the activated phosphorylase
(phosphorylase a) converted glucose-1-phosphate to glycogen
with formation of inorganic phosphate, which was visualized
with a colorimetric Fiske–Subarow reaction. As sources of
phosphorylase-b-kinase and its kinase (now known as cAMP-
dependent protein kinase or PKA), I used a crude glycogen
preparation isolated from rabbit skeletal muscle which I knew
came with glycogen metabolizing enzymes adsorbed to it. TheFig. 1. Epinephrine increases and insulin opposes and reverses the epinephrine-
induced increase in cAMP levels in isolated fat pads. (Adapted from Butcher
et al., 1966 [1]).phosphorylase b in the assay came from a batch of rabbit
muscle enzyme I had crystallized during my thesis work guided
by Micheal Appleman, who was doing his postdoctoral work
with Luis Leloir at the Institute for Biochemical Research
“Fundación Campomar” in Buenos Aires. Leloir, who with
Héctor Torres had co-signed my PhD thesis, directed the
Campomar Foundation, and would later receive the 1970 Nobel
Prize in Chemistry for the discovery of sugar nucleotides a few
years before I had come to the Campomar laboratories. It is
difficult to describe my surprise, when on that first day, Rodbell
showed me a brand new assay for measuring adenylyl cyclase
based on conversion of [α-32P]ATP – 3 million cpm per assay
tube; purchased from ICN – to [32P]cAMP, that could be
completed in an hour or so. The assay gave a blank of 150–
200 cpm, a basal activity of 300–350 cpm and an ACTH-
stimulated activity of 450–500 cpm. The method to isolate the
[32P]cAMP was easy, fast, and vastly superior to the Sutherland
assay, and consisted of a two-step separation of the reaction
product from the substrate and its breakdown products. This
separation was based on Gopal Krishna's observations that
cAMP was retarded on a Dowex50-H+ column, eluting after the
bulk of the unconverted [32P]ATP and its hydrolytic products
[32P]ADP and [32P]AMP, and that 32P-labeled products that still
contaminated the [32P]cAMP in the Dowex 50 eluates could be
adsorbed onto a nascent mixture of BaSO4/Zn(OH)2. The [
32P]
cAMP formed by the enzyme was recovered in the supernatant
after a short spin in a table top clinical centrifuge and quantified
by liquid scintillation counting. For the next months I worked
side by side with Martin Rodbell and his technician, Ann Butler,
on the final validation steps of the assay, improving conditions,
reducing variability and on increasing our assay capacity to
more than the 20 columns that Rodbell was handling when I
first came. The NIH Machine Shop made racks that held the
Dowex columns in 5 rows of 10; we purchased a Sorval GLC-1
benchtop centrifuge in which we could spin the BaSO4/Zn
(OH)2 suspensions, 48 tubes at a time, and added higher levels
of unlabeled ATP, theophylline, EDTA, and an ATP regenerat-
ing system to improve linearity of cAMP production as a
function of time. Authentic [3H]cAMP was added at the end of
the assays to monitor recovery in the BaSO4/Zn(OH)2
supernatant.
Sometimes addition of insulin appeared to reduce stimula-
tion of the fat cell ghost adenylyl cyclase by ACTH or
epinephrine, but this was highly variable.
I had arrived on a stormy January 31st, 1967. On July 1st,
Rodbell left for what turned out to be a 16-month sabbatical stay
in Albert Renold's Institute of Clinical Biochemistry at the
University of Geneva, to investigate other effects of insulin on
fat cells. Left alone with a solid training in enzymology from my
graduate student time in Leloir's institute, and a capacity to run
up to 100-tube assays per day, I continued characterizing the
adenylyl cyclase from an enzymological view point. A typical
day started at 9 am with the arrival of 20 male Sprague–Dawley
rats from which I dissected epididymal fat pads, which were
digested in a medium with collagenase, to then prepare free fat
cells by passing the digested tissue through silk screen and
floating the cells away from remaining debris by a short 15-s
Fig. 2. Adenylyl cyclase as an epinephrine receptor model. (Adapted from
Robison et al., 1967 [3]).
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a hypotonic medium and lysed them by gently inverting the
tubes with the cells 10 times, as Rodbell had taught me. Upon
lysis the cells released their fat, as well as most of their contents,
resealing immediately thereafter, and yielding sacs that Martin
Rodbell called “fat cell ghosts”, and I often referred to as
“anemic fat cells”. They had lost about 80–90% of their
cytoplasmic content, retaining nuclei, some mitochondria, and
an active hormone-sensitive adenylyl cyclase system. These
membrane sacs were collected as a pellet in the benchtop
centrifuge.
I generated time courses at low and high ATP, and pH curves,
plus and minus insulin. I assayed activity at low and high Mg2+,
without and with EDTA in the assay, plus and minus insulin. I
tested the effect of different monovalent cations at low and high
Mg2+, in the absence and presence of EDTA or EGTA, plus and
minus insulin. I always tested for basal and ACTH- and
fluoride-stimulated activities. Fluoride had been shown by
Sutherland's group to stimulate adenylyl cyclase activity by a
mechanism equally obscure as the one by which hormones
stimulated activity, but unrelated to fluoride's ability to inhibit
ATPases that hydrolyze the substrate. I discovered that EGTA,
but not EDTA, abolished stimulation by ACTH and documen-
ted a requirement for Ca2+ in the action of ACTH, but not in that
of glucagon or epinephrine, the other two hormones I was often
testing for their ability to stimulate adenylyl cyclase. Spor-
adically there seemed to be a reduction in cAMP formed in the
presence of insulin. But these effects were never reproducible. I
wrote weekly letters to Rodbell — by hand, on thin airmail
paper. Once I thought that I had it, and wrote that definitely
there seemed to be an effect of insulin if I used very low Mg2+,
but that he should not tell anybody until I could confirm it better.
He promptly mentioned it at that year's Laurentian Hormone
Conference – August 1967 – and it appears in the record of the
discussion that followed his presentation. Marty made me a co-
author on his chapter for this contribution (Rodbell et al.,
1968 [2]).
Spurred by ACTH's requirement for Ca2+, I wondered
whether ACTH was acting on the same enzyme as epinephrine
and glucagon. Sutherland's group had proposed hormone-
sensitive adenylyl cyclases to be a family of single molecules,
each hormone interacting with its adenylyl cyclase (Fig. 2,
adapted from Robison et al., 1967 [3])1. If so, the effects of
epinephrine and ACTH should have been additive. They were
not. Moreover, propranolol, a beta-adrenergic receptor blocker,
inhibited only the effect of epinephrine, leaving those of ACTH
and glucagon untouched. It became clear that the hormone
binding sites, the receptors, were separate from adenylyl
cyclase, a theme we would explore in more detail after
Rodbell's return from Europe.1 It should be noted that if instead of studying adenylyl cyclase I would have
been looking into the mechanism of action of growth factors acting through
receptor tyrosine kinases — e.g. epidermal growth factor (EGF) or platelet
derived growth factor (PDGF) or at guanylyl cyclases — e.g. atrial natriuretic
peptide- (ANP) or guanylin-stimulated cGMP formation — Sutherland's view
would have been on target: each receptor molecule is also the effector enzyme.The relationship between ATP and Mg ion baffled me.
High ATP was inhibitory at low Mg2+ but not at high Mg2+,
high Mg2+ would stimulate absolute activity more in the
absence than the presence of hormone. I eventually designed a
matrix experiment, in which I varied both variables simulta-
neously. It took me about a week to plan the experiment and to
calculate mixtures in which I varied both, unlabeled and
radioactive ATP, so as to economize the use of the labeled
compound. Labeled ATP was expensive — $240/mCi, and I
must have used my weekly allowance of 5 mCi for this single
experiment. Calculations were done by hand and slide rule —
the programmable Wang calculator would arrive 2 years later;
Neil Armstrong had not yet set foot on the Moon. The day
before the assay, I numbered the 10×75 mm test tubes I would
use, which I had washed the previous day by overnight
submersion into chromosulfuric cleaning solution. In fact, I
washed tubes every day, leaving them drying overnight for use
on the next day, while the new batch was soaking in the red-
brown sulfuric acid mix for rinsing the next day. Nowadays,
disposable tubes are clean and can be used directly. The day of
the matrix experiment, I started very early, pipetted the reaction
mixes and placed them on ice before starting the fat cell-fat cell
ghost preparation. Although normally I had no access to
technical help, for this experiment, I had the help of Ann Butler:
I started the reactions by adding 10-μl aliquots of ghost
suspension to 40 μl of pre-pipetted mix and placed the tube into
the 30 °C Dubnoff shaking incubation bath, and she stopped the
reaction 10 min later with a “stop” solution containing cold
ATP, carrier cAMP, labeled [3H]cAMP and sodium dodecyl-
sulfate, all at 15 s intervals.
The results from the matrix experiment were important
(Fig. 3A). For one, they ordered and made sense of the many
previous experiments where I had measured the ATP-depen-
dence of the enzyme at one or another Mg2+ concentration, or
measured the effect of varying Mg2+ at one or another
concentration of ATP. Moreover, it gave me the first good
insight into the fact that the mechanism by which fluoride and
hormone stimulated activity should basically be the same, or if
Fig. 3. (a) The Matrix Experiment: Dependence of basal (middle panels), fluoride- (top panels), and ACTH- (bottom panels) stimulated adenylyl cyclase activities in
fat cell ghosts on the concentrations of ATP (left panels) at the indicated MgCl2 concentrations, and on the concentration of MgCl2 (right panels) at the indicated
concentrations of ATP. A, direct plot of data. (b) The Matrix Experiment: B, replot of the fitted curves according to Hill. (From Birnbaumer at al., 1969 [4]).○, basal
activity; ▲, fluoride-stimulated activity; ●, ACTH-stimulated activity; ACTH, adrenocorticotropin.
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dependence of activity on ATP followed pretty much
Michealis–Menten kinetics with an apparent Km of 0.1–
0.2 mM, when assayed in the absence of hormone or fluoride.
In contrast, for both hormone- and fluoride-stimulated activ-
ities, the dependence on ATP showed some cooperativity and
appeared not to saturate until above 3–5 mM. Hence, relative
stimulations by hormone and fluoride were higher at high than
at low ATP. The dependence on Mg2+ (in excess of ATP plus
EDTA in the assay), was clearly cooperative for all threeactivities, basal, hormone- and fluoride-stimulated, with a Hill
coefficient of 2 for all three, but differing in that hormone and
fluoride activities were left-shifted along the Mg2+ concentra-
tion axis with respect to basal (Fig. 3B). The activation
mechanism, I concluded, was one of lowering the enzyme's
requirement for Mg2+. The fact that the apparent Km for ATP
was right shifted for hormone and fluoride-stimulated activities
with respect to basal, was a puzzle for which the explanation
became clear only after we had learned about the GTP effect on
glucagon binding.
Fig. 5. Late 1969 representation of the hormone sensitive adenylyl cyclase as a
system formed of three functional elements: Discriminator, Transducer and
Amplifier. (From Rodbell et al., 1970b [7]).
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insulin, but with the results at hand, I tested for an effect of
insulin at critical points along the ATP–Mg2+ continuum, and
eventually settled concluding that there was no effect. Now we
know that the reduction of cAMP levels observed by
Sutherland's group had been due to activation of the
phosphodiesterase — I had been looking at the wrong enzyme.
After the matrix experiment, I re-focused on the interdepen-
dence of the stimulation of the ghost adenylyl cyclase by
hormones. From Mathys Staehelin at CIBA, Rodbell received
an ACTH analog with four D-amino acids substituting for their
corresponding L-amino acids. It proved to be a competitive
inhibitor that did not affect stimulation by either glucagon or
epinephrine. Later, we tested a glucagon homologue, des-His1-
glucagon, given to us by Finn Sundby from the Novo Research
Institute in Denmark, and found it to block the action of
glucagon without affecting those of ACTH and epinephrine. It
became clear to us that receptors had to be molecules that were
separate from adenylyl cyclase. Fat cell adenylyl cyclase and
lipolysis was also stimulated by LH, a glycoprotein hormone,
and we proposed the model shown in Fig. 4: several hormone
receptors affect a single adenylyl cyclase by changing its
interaction with Mg2+.
Eventually, Martin Rodbell returned from his sabbatical in
Europe. This had two consequences. I had an ear for my
thoughts and the size of the group expanded to include Steve
Pohl, a research associate, who arrived 2 months before Marty's
return, and Michiel Krans, a Dutch fellow, who arrived a few
months after Rodbell. Tom Demar joined us as well to take care
of us and make sure we had clean materials to work with. We
also expanded from the single 200 sq. ft laboratory in which
Rodbell and Ann Butler had shown me the adenylyl cyclase
assay, to a second 200-sq. ft laboratory on the 8D corridor of
Building 10. Steve helped me to bring the data on the kinetics of
the fat cell adenylyl cyclase to a publishable form, and in
February 1969 we submitted two papers to the J. Biol. Chem.,
one on the fat cell enzyme properties including the matrix
experiment (Birnbaumer et al, 1969 [4]), and the other on theFig. 4. 1969 conceptualization of an adenylyl cyclase system stimulated by
multiple hormones, each interacting with a separate receptor having two
domains: a ligand binding domain responsible for hormone specificity and a
common adenylyl cyclase domain allowing each to interact with a common
adenylyl cyclase where they affected the dependence of the enzyme on Mg.
Fluoride is viewed as acting by bypassing the hormone receptors, but effecting
the same kinetic parameter. (From Rodbell et al.,1970b [7]).existence of separate hormone receptors acting on a common
adenylyl cyclase system (Birnbaumer and Rodbell, 1969 [5]).
When secretin, purified by Victor Mutt and Erik Jorpes at the
Karolinska Institute in Stockholm, was shown to be lipoplytic,
we tested its effect on the fat cell adenylyl cyclase and found it
too to stimulate through a receptor site distinct form those
mediating the effects of epinephrine, ACTH and glucagon
(Rodbell et al., 1970a [6]).
We began thinking of a transduction mechanism and of Mg2+
as an integral part of this mechanism. We began speaking of
discriminators, transducers and amplifiers (Fig. 5), which now
correspond to GPCRs, G-proteins and effectors, but then were
just concepts that facilitated communication. The role of GTP
still had to be discovered and our thoughts were more on the
side of phospholipids playing key roles in transduction, as
different detergents had distinct and non-linear effects (Rodbell
et al., 1970b [7]).
In spite of the beauty of the adenylyl cyclase system in fat
cell ghosts, it was not very amenable to biochemical study. Fat
cell ghosts could not be frozen and thawed with preservation of
hormone-stimulated adenylyl cyclase activity. This required us
to prepare fresh fat cells every day. The original work by
Sutherland and colleagues leading to the identification of cAMP
as a second messenger had been done with dog liver
homogenates, in which they found that glucagon and
epinephrine were able to activate phosphorylase. They had
gone on to show that the hormones interacted with the
particulate fraction to generate a heat stable factor – cAMP –
that then caused the activation of phosphorylase in the
supernatant in which the hormones were unable to promote
phosphorylase activation (Berthet et al., 1957 [8]). From David
Neville at the National Institute of Mental Health (NIMH), we
obtained a highly purified preparation of liver plasma
membranes which Steve Pohl tested for presence of epinephrine
and glucagon responsive adenylyl cyclase. Even though the
liver membrane adenylyl cyclase was not stimulated by
epinephrine, it had a robust response to glucagon that was the
same in fresh and frozen membranes (Pohl et al., 1969 [9]). We
taught Tom Demar to prepare Neville membranes, as we called
them, and had him make industrial quantities that went into
tubes stored in liquid nitrogen. This allowed us to pull out what
we needed when we needed, without having to worry about
their replenishment. Steve and I began studying the properties
of the liver plasma membrane system and to establish
similarities and differences between liver and fat cell adenylyl
cyclases (Pohl et al., 1971 [10]; Birnbaumer et al., 1971 [11]). In
parallel, Rodbell with Michiel Krans began to work on labeling
Fig. 6. The binding of 125I-glucagon to liver plasma membranes: Effect of GTP
to accelerate the interaction rates. (Adapted from Rodbell et al., 1970c).
Fig. 7. Rapid activation of liver adenylyl cyclase by glucagon and its fast
reversal. (From Birnbaumer et al., 1972 [78]).
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binding of glucagon to liver membranes with the intention of
characterizing the liver glucagon receptor.
At that time this was the logical next step in researching the
mechanism of action of hormones, and we were not the only
ones to take this course of action. In fact several studies of this
type were being done quite near to us. But who was doing what,
was not always known to me. I knew that Pierre Freychet, a
visiting fellow from France with Jessie Roth, had labeled insulin
with 125I in a laboratory around the corner of ours and was
validating an insulin receptor binding assay that laid the
foundations of the present understanding of insulin's interaction
with its receptor (Freychet et al., 1971a [12]; and b [13]). But I
did not know that Kevin Catt, who had experience in setting up
radioimmunoassays, and hence in hormone labeling techniques,
was beginning to study binding of 125I-labeled hCG to testis
membranes at the other end of Building 10 (De Kretser et al.,
1971 [14]; Catt et al., 1971 [15]). I also did not know that Robert
Lefkowitz, who worked in Ira Pastan's laboratory and off and
on used one of our two liquid scintillation counters — ‘Hi’ he
would say ‘I am Bob Lefkowitz. I work in Ira Pastan's lab. Can I
use your scintillation counter tonight?’ — was working on an
ACTH binding assay with adrenal membranes. Maybe this was
because I was too encapsulated in my own world. This world
had 1000% of my attention. Marty and Michiel, after several
trials, had settled on labeling glucagon with 125I using low
concentrations of chloramine T as catalyst. I set up ISCO's
preparative polyacrylamide gel electrophoresis system to which
we applied the full iodination reaction, containing 1 mCi of 125I.
I gave the fractions from the electrophoresis to Michiel and
Marty to test for binding to liver membranes. Glucagon was
very sensitive to damage by oxidation and the reaction mix had
several labeled peaks, of which one bound to the membranes
with the expected characteristics: specific for glucagon, as it
was not prevented by excess ACTH or secretin, but was
prevented by unlabeled glucagon. Moreover, the binding
occurred over a concentration range similar to that over which
glucagon stimulated the liver adenylyl cyclase activity (Rodbell
et al., 1971a [16]). The binding assay was simple: membranes
were incubated with 125I-labeled glucagon in the presence of
1% albumin, a Tris buffer, 1 mM EDTA, and additives such as
unlabeled glucagon, ions, etc. The reaction was stopped by
layering the reaction mixture on top of a 10% sucrose solutionin a Beckman polyethylene microfuge tube, followed by a 5 min
spin in the cold room — I remember Michiel rushing from lab
to cold room (exactly across from the lab), starting the
microfuge, hurrying back to the lab, where Marty was removing
the next five samples from the incubation bath, overlaying them
on sucrose and giving the tubes to Michiel for centrifugation.
All done at 5 min intervals. The tube tips (bottoms) with the
washed and pelleted membranes were then cut off with a scalpel
and 125I retained by the membranes was quantified in a gamma
ray scintillation counter.
We thought we had a receptor assay, and presented some of
our results at a colloquium on “The Role of Adenyl Cyclase and
3′5′-cyclic AMP in Biology”, held in November 1969 at the
Fogarty Center on the NIH Campus (Rodbell et al., 1970b [7]).
At this same meeting, Bob Lefkowitz presented some of his data
on preparation of iodinated ACTH and its interaction with
adrenal membranes, published soon thereafter (Lefkowitz et al.,
1970 [17]). Before submitting our data for publication, we still
performed a time course study which however gave an
unexpected result. At 5 nM of 125I-glucagon, the binding
reaction took about 20 min to reach equilibrium. And, while
addition of glucagon at time zero prevented 125I-glucagon from
binding, post-addition at 20 min resulted in very slow release of
the labeled hormone (Fig. 6). Functional studies with the same
membranes in which we stimulated adenylyl cyclase activity
with 4–5 nM labeled or unlabeled glucagon, a concentration
that caused an activation that was about 50% of maximal, gave
time courses of cAMP accumulation, taken at 30 s intervals, that
extrapolated to the time of glucagon addition (Fig. 7) and did
not show the lag-time predicted by the time course of “receptor”
occupancy. Moreover, post-addition of des-His1-glucagon, the
competitive inhibitor of glucagon's ability to activate adenylyl
cyclase, stopped the activation by glucagon with at most a 30 s
delay (Fig. 7), an effect that was predicted by the binding study
to be quasi irreversible (Fig. 6).
Since there was a clear difference in the incubation
conditions used for measuring adenylyl cyclase and those at
which we were measuring glucagon binding, we decided to
carry out the binding assay under adenylyl cyclase assay
2 Even though we had discovered a requirement for GTP in hormonal
stimulation of adenylyl cyclase by following up on the finding that GTP
affected binding of 125I-glucagon to liver membranes, and the role of GTP was
becoming understandable, binding of 125I-glucagon to liver membranes in the
presence of GTP was still too slow to be responsible for the stimulatory effect
seen with glucagon: the cyclase reached steady state activation within seconds
but 125I-glucagon binding continued to increase for minutes on end (Fig. 6),
without visible change in activity (Fig. 7). Mistakenly, I assumed that we were
looking at two or more types of binding sites, of which some — a few-coupled
to adenylyl cyclase, but the majority played no functional role, being acceptor
sites instead of receptors (Birnbaumer et al., 1974 [76]). The conundrum was
solved 12 years later, with the characterization of two iodinated forms of
glucagon: one [I-Tyr10]glucagon, being biologically active and binding with a
5- to 8-fold higher affinity and full cyclase stimulating activity than the parent
un-iodinated glucagon, and the other [I-Tyr13]glucagon, that bound with lower
affinity and did not activate adenylyl cyclase (Rojas et al., 1983 [77]). Instead
of dealing with a heterogeneous set of binding sites, we had been dealing with a
heterogeneous set of iodinated glucagons. In the presence of GTP, the active
[125I-Tyr10]glucagon bound rapidly and dissociated accordingly, while the [125I-
Tyr13]glucagon bound slowly. This product had been the bulk of the iodinated
material we had been offering to the membranes and thus led to the bulk of the
observed binding.
Fig. 8. Essential role for GTP in the activation of liver adenylyl cyclase by
glucagon. (From Rodbell et al., 1991c [19]).
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regenerating system (creatine kinase and creatine phosphate).
The result was again unexpected: in a 15 min binding assay,
addition of adenylyl cyclase assay reagents decreased the
amount of 125I-glucagon bound by about 50% (Rodbell et al.,
1971b [18]). Little did we know that we had just found the
“GTP effect” and that this finding would be the beginning of the
“signal transduction by G proteins” era. In fact the term signal
transduction did not yet exist, though no doubt it would evolve
from the transducer function we were proposing to intervene
between hormone binding and adenylyl cyclase activation.
Of the reagents added, we rapidly learned that it was the ATP
that reduced binding. As to specificity, GTP and ATP, but not
UTP or CTP, were effective, and, to our surprise, GTP was
effective at 1000 times lower concentrations than ATP. Among
different guanine nucleotides, the only other form able to reduce
binding was GDP (Rodbell et al., 1971b [18]). Nelson Goldberg,
who had developed an assay for cGMP based on its hydrolysis to
5′GMP and subsequent enzymatic conversion to GTP, and
depended on the purity of ATP used to phosphorylate GMP to
GTP, had recently reported that commercially available ATPwas
contaminated with GTP, varying from a low of 0.1% up to 5%
and even 10%. It became clear therefore that I had never
measured adenylyl cyclase activity without adding GTP. The
possibility arose that GTP might be necessary for hormonal
activation of adenylyl cyclase. This might be the reason that high
levels of ATP were needed to observe robust hormonal
stimulations relative to basal activity in the matrix experiment.
We split tasks. I looked for a functional correlate to the GTP
effect on binding at the level of adenylyl cyclase activity, using
the assay I had been using, while Marty Rodbell sought to
develop an alternate substrate for adenylyl cyclase: AMP-PNP,
now AMP-P(NH)P (Rodbell et al., 1971c [19]).
Rodbell synthesized [α-32P]AMP-P(NH)P from [α-32P]ATP
and P(NH)P, which he obtained from Ralph Yount at
Washington State University (Pulman, WA). Yount had shown
that AMP-PNP could replace ATP in the allosteric regulation of
the muscle actomyosin ATPase, without being a substrate for
the ATPase. Rodbell's idea was that if AMP-P(NH)P was a
substrate for adenylyl cyclase he might be able to test for
regulatory effects of GTP and ATP that might not be mimicked
by AMP-P(NH)P.
On my side, I found what I already knew, i.e., that at very
low ATP I could not obtain a robust stimulation by glucagon,
and that addition of either ATP or (and this was new) GTP, led to
robust stimulation of adenylyl cyclase by glucagon. Rodbell's
approach proved to be more definitive. Using an enzymatic
approach based on the three-step synthesis of aminoacyl
tRNAs, in which an intermediate of the form [amino
acyl∼ tRNA∼AMP] is formed from ATP and amino acid,
that can decay to back to amino acid, tRNA and ATP, if excess
PPi is added, he drove the intermediate to form AMP-P(NH)P
by adding excess P(NH)P and made [α-32P]AMP-P(NH)P from
[α-32P]ATP and P(NH)P. [α-32P]AMP-P(NH)P proved to be a
substrate for adenylyl cyclase, which could now be assayed for
hormonal stimulation under conditions that would not lead to
transphosphorylations among GTP and ATP. Addition ofglucagon still stimulated activity when added to the incubation
at the same time as liver membranes. But, addition of glucagon
10–15 min after the cyclase reaction had been started, yielded
no increase in activity unless GTP was also added (Fig. 8).
At the level of 125I-glucagon binding, addition of GTP was
found to accelerate both, dissociation and association. Binding
was now reversible, which it was only very poorly in the its
absence; addition of GTP to membranes with pre-bound 125I-
glucagon caused it to dissociate (Fig. 6). We also determined
that the reduction of 125I-glucagon-binding observed when we
had added adenylyl cyclase assay reagents – now GTP –
resulted from the fact that the rate of the dissociation was
increased more than that of association, so that binding as a
function of 125I-glucagon concentration was right shifted by a
factor of about 3- to 5-fold. Accordingly, at equilibrium the
occupancy of the binding site was lower in the presence of GTP
than in its absence (Fig. 9)2.
We speculated that actions of hormones could be regulated
from within the cell and were not necessarily an obligatory
consequence of simple changes in the hormone's circulating
Fig. 10. Late 1970 model of the glucagon-sensitive liver membrane adenylyl
cyclase viewed as an information transfer system, incorporates the effects of
GTP and ascribes a role for GTP in signal transduction.
Fig. 9. The effect of GTP to decrease the apparent affinity of the liver glucagon
receptor for its ligand. (From Rodbell et al., 1971c [19]).
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action of GTP. In March 1970, we drew the model shown in Fig.
10, in which rapid binding of glucagon had a driving force
operating on the transducer which then acted on adenylyl
cyclase increasing its activity. Whether or not the GTP-binding
transducer was a molecule separate from either receptor or
adenylyl cyclase, was not addressed (Rodbell et al., 1970c [20]).
Evidence for the existence of a separate molecule with a
transducer function came from three quite independent research
lines. Two were logical extensions of the line initiated by the
GTP effects on glucagon binding and its role in glucagon
receptor-mediated activation of the adenylyl cyclase system.
The third, while prompted by the nucleotide requirement in
hormonal activation of adenylyl cyclase, focused on biochem-
ical changes occurring in rod photoreceptor cells upon
illumination.
3. Paths to G proteins
By mid 1971, Steve Pohl and I had left Martin Rodbell's
laboratory. Michiel Krans had also left, returning to the
University of Leiden where he had an assistant professorship
waiting for him in the Division of Metabolism and Diabetes of
the Department of Medicine. Bob Lefkowitz had also left the
NIH to take a position at the Massachusetts General Hospital,
where he began working on a beta-adrenergic receptor binding
assay using [3H]norepinephrine as a ligand. After us, Rodbell
filled his laboratory with a new research team, his second, as I
had been his first postdoctoral fellow. Among the members of
this new team was a very tall man, Martin Low, who had come
from the Karolinska Institute to spend a sabbatical with Rodbell.
Low took the fat cell system to the next step and prepared highly
purified membranes in which the cyclase system became stable.
And with stability came absence of stimulation by hormones –
previously seen also by Leonard Jarett (Jarett et al., 1971 [21]) –
but in contrast to Jarett, Low was now able to restore hormonal
activation by addition of GTP. Changing assay conditions then
showed that GTP could have both positive and negative effects
– a preview of Gs and Gi (Harwood et al., 1973 [22]) – and that
this applied to both hormonal as well as fluoride stimulation
(Harwood and Rodbell, 1973 [23]). In my new lab, atNorthwestern University in Chicago, I made similar observa-
tions about dual regulation of adenylyl cyclase, but in renal
membranes where GTP and ATP improved stimulation by
vasopressin, while stimulation by PGE1 was reduced by GTP
(Birnbaumer, 1973 [24]). And Gopal Krishna, then an
investigator in B.B. Brodie's Biochemical Pharmacology
Branch of the National Heart Institute, found that the human
platelet prostaglandin-stimulated adenylyl cyclase behaved
exactly the same as the rat's liver membrane adenylyl cyclase.
It required GTP or ATP to show stimulation by PGE1 when, by
now commercially available, [α-32P]AMP-P(NH)P was used as
substrate (Krishna et al., 1972 [25]). This in fact was the first of
many reports on a role for GTP or ATP in hormonal stimulation
or inhibition of adenylyl cyclase.
4. Activation of adenylyl cyclase by hormones involves a
GDP/GTP nucleotide exchange reaction and its
deactivation is coupled to GTP hydrolysis: the
hormone-stimulated GTPase
As interesting as these results may have been, the next
breakthrough in our – the field's – way of thinking came from
two different sides. One was Rodbell's invention in 1974, of
GMP-P(NH)P, (or “gimpimp” as he called it). This non-
hydolyzable GTP analogue proved to be a “super-stimulator”
of adenylyl cyclases (Londos et al., 1974 [26]): while GTP itself
increased basal activity only minimally, compared to its effect
on hormonal stimulation, GMP-P(NH)P was by itself as
effective in stimulating activity as the combination of hormone
and GTP. But instead of being a rapid activator of adenylyl
cyclase, activation by GMP-P(NH)P exhibited a lag. This lag
was abolished by addition of hormone, and the resulting
activation became irreversible — resistant to washing
(Schramm and Rodbell, 1975 [27]). In turkey erythrocytes,
this lag was so extended that in a standard 10 min incubation,
GMP-P(NH)P showed essentially no stimulatory effect unless
hormone (isoproterenol) was added. Clearly hormones were
accelerating the rate at which GMP-P(NH)P acted.
Could it be that instead of a requirement for GTP in the
action of hormones, there was a requirement for hormone in the
action of GTP? The importance of this question is that it shifted
the emphasis from asking how hormone acted to how GTP
acted. GMP-P(NH)P had become an essential tool to address
this question. In his article on GMP-P(NH)P being a “super”
GTP, Rodbell raised the question whether the persistence of the
Fig. 12. Cassel and Selinger's 1978 model of the mechanism of hormonal
activation of adenylyl cyclase incorporating the role of hormone [receptor] as a
nucleotide exchange factor and an intrinsic GTPase responsible for deactivation
of the system, and the effect of cholera toxin to activate the system by blocking
the GTPase, the adenylyl cyclase turn-off reaction. (From Cassel and Selinger,
1978 [33]).
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P(NH)P not being susceptible to hydrolysis and speculated that
the faster action and lower effect of GTP on basal activity might
imply the existence of a GTPase closely associated with
adenylyl cyclase (Londos et al., 1974 [26]).
The next advance in our understanding of the hormone-
stimulated adenylyl cyclase came from the finding in Zvi
Selinger's laboratory of a hormone stimulated GTPase. Work-
ing with turkey erythrocyte membranes, Selinger and his
graduate student, Dan Cassel, set out to test Rodbell's GTPase
idea and discovered an isoproterenol-stimulated, low Km
GTPase (Cassel and Selinger, 1976 [28]). Activation of the
GTPase was independent of adenylyl cyclase activity, as
stimulation of the GTPase by isoproterenol was unaffected in
membranes in which adenylyl cyclase had been inactivated with
p-chloromercuribenzoate. Cassel and Selinger also studied the
mechanism by which cholera toxin activated adenylyl cyclase.
Adenylyl cyclase activation by cholera toxin had been reported
by Geoffry Sharp and Sixtus Hyenie (Sharp and Hyenie, 1971
[29]), who in turn had followed up observations by Martha
Vaughan and William Greenough that choleragen activated
lipolysis – a cAMP stimulated process – in fat cells (Vaughan et
al., 1970 [30]), and by Nelson Goldberg that cholera toxin
elevated cAMP levels in intestinal mucosa (Schafer et al., 1970
[31]), where cAMP promoted water secretion. Cassel and
Selinger confirmed that cholera toxin activated adenylyl
cyclase, and found that cyclase activation went hand in hand
with loss of hormone-stimulated GTPase activity (Fig. 11). It
appeared that cholera toxin by inhibiting GTP hydrolysis,
converted this nucleotide in a super-stimulator akin to GMP-P
(NH)P. They proposed a mechanism in which adenylyl cyclase
existed in two forms, an active form with GTP bound to it, and
an inactive form resulting from hydrolysis of GTP to GDP plus
Pi. Activation by cholera toxin was viewed as the result of
inhibiting the active to inactive conversion — the GTPase
reaction. Hormone [receptor] was initially viewed as stimulat-
ing the binding of GTP which led to the inactive to active
adenylyl cyclase transition (Cassel and Selinger, 1977 [32]). In
another study, Cassel and Selinger showed that the adenylyl
cyclase, irreversibly activated by incubation with GMP-P(NH)P
and isoproterenol, could be deactivated by a second incubationFig. 11. Cholera toxin treatment results in activation of adenylyl cyclase while at
the same time it reduces hormone-stimulated GTPase in turkey erythrocyte
membranes. (From Cassel and Selinger, 1977 [32]).with isoproterenol and GMP, and that this correlated with
release of prebound [3H]GMP-P(NH)P (Cassel and Selinger,
1978 [33]). Moreover, incubation of turkey membranes with
[3H]GTP and isoproterenol, followed by washing, resulted in
the retention of [3H]GDP, which could be released by further
incubation with isoproterenol (Cassel and Selinger, 1978 [33]).
Thus, Cassel and Selinger were the first to completely grasp and
propose that the mechanism by which hormones activate
adenylyl cyclase involves the activation of a nucleotide
exchange reaction that causes the release of GDP and the
binding of GTP (Fig. 12). The hormone-stimulated GTPase
activity is therefore merely the reflection of the increased
cycling rate between inactive and active states. The confirma-
tion that Cassel and Selinger's model was correct took 5 years,
required reconstitution of the hormone-stimulated GTPase from
separate components and involved an independent research
team, working on another continent with a different set of tools,
including the purified, yet to be discovered regulatory
component of adenylyl cyclase, now known as Gs (Brandt et
al., 1983 [34]).
5. The catalytic activity and the regulatory guanine
nucleotide binding site of adenylyl cyclase reside on
separate molecules
The introduction of GMP-P(NH)P as a potent activator and
stabilizer of adenylyl cyclase activity led to the testing of other
modified GTP analogues, notably GMP-P(CH2)P and GTPγS,
of which GTPγS proved to be equivalent to GMP-P(NH)P. The
stabilizing effect prompted the German biochemist Thomas
Pfeuffer in Wuerzburg to attempt the solubilization and
purification of the activated enzyme, following both its
enzymatic activity and its guanine nucleotide binding activity
(Pfeuffer and Helmreich, 1975 [35]; Pfeuffer and Eckstein,
1976 [36]). These studies revealed that the binding component
and the enzyme could be separated either by differential
extraction, or by size fractionation techniques (Pfeuffer and
Helmreich, 1975 [35]). Eventually these studies led Pfeuffer to
develop a GTP-affinity matrix, to which GTP was covalently
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phosphate. After membrane solubilization this affinity matrix
retained the GMP-P(NH)P-binding component suspected of
being responsible for adenylyl cyclase activation, allowing
adenylyl cyclase to flow through. Cyclase activity in the flow
through had a much diminished response to GMP-P(NH)P or
fluoride and washes with GTP had no measurable adenylyl
cyclase activity, but, when combined with the flow through,
restored the ability of fluoride to stimulate activity (Pfeuffer,
1977 [37]). Thus, the GTP-binding component appeared to also
be the component responsible for fluoride stimulation (Fig. 13).
Polyacrylamide gel electrophoresis showed the GTP binding
component to have an apparent molecular weight of 42,000 Da.
By an interesting coincidence the 1977 Oct 25 issue of the
Journal of Biological Chemistry carried two landmark papers on
the same subject. One was Thomas Pfuffer's full length article
on the reconstitution of fluoride-stimulated activity by a
guanine nucleotide-binding component (Pfeuffer, 1977 [37]).
The other was a short communication by Elliott Ross and Alfred
Gilman, then at the University of Virginia, Charlottesville, on
the resolution of a hormone and fluoride stimulated adenylyl
cyclase system into an enzyme proper and a stimulatory
regulatory component mediating the activation by guanine
nucleotides and fluoride (Ross and Gilman, 1977 [38]). This
discovery would later earn Alfred Gilman the sharing with
Martin Rodbell of the 1994 Nobel Prize in Medicine for the
discovery of the G protein mediated signal transducing systems.
Ross and Gilman's discovery had been made possible by the
creation in 1975 by Gordon Tompkins' research group at UCSF
in California, of a S49 mouse thymoma cell mutant resistant to
the killing (i.e., apoptotic) effect of cAMP, in which no adenylyl
cyclase activity could be measured (Bourne et al., 1975 [39]).
Then referred to as AC−, the cell turned into the Rosetta Stone
of adenylyl cyclase research as it was to evolve in subsequent
years. What Ross and Gilman showed was that a detergent
extract of wild type S49 cell membranes, that had been heated to
inactivate all measurable adenylyl cyclase activity, was able to
reconstitute hormone- and fluoride-stimulated adenylyl cyclase
activities in AC− cell membranes. Careful examination of AC−Fig. 13. A GTP binding protein mediates activation of adenylyl cyclase by
fluoride. (Adapted from Pfeuffer, 1977 [37]).membranes for adenylyl cyclase activity showed that they were,
in fact, not negative for adenylyl cyclase activity. When assayed
with Mn2+ as the divalent cation, AC− membranes still
catalyzed conversion of ATP to cAMP, albeit at a much reduced
rate, which with Mg2+ was so low that it had been missed. The
AC− adenylyl cyclase was unresponsive to hormone, GMP-P
(NH)P or fluoride. There was no cyclase activity in the heat-
treated wild type S49 cell membrane extract, which therefore
contributed the missing, more heat stable, regulatory compo-
nent, that conferred hormonal, nucleotide and fluoride regula-
tion to the system (Ross and Gilman, 1977 [38]).
As published in 1980, Gilman's laboratory had gone on to
use the reconstitution of fluoride-stimulated adenylyl cyclase
activity in AC− membranes as an assay to purify the GTP-
binding regulatory component of adenylyl cyclase, thus
defining in molecular terms what is today referred to as signal
transduction by G proteins (Northup et al., 1980 [40]).
6. Cholera and pertussis toxins are covalent modifiers of
two regulatory components of adenylyl cyclase
In 1975, the in vitro adenylyl cyclase stimulating activity of
cholera toxin (CTX), an A1B5 heterohexamer, was shown by
Michael Gill at Harvard to exert its intracellular action via the
29 kDa A subunit and to require NAD+ as a cofactor (Gill, 1975
[41]). The entry of the A subunit into cells had been shown to
depend on the attachment of the B pentamer to cell surface
gangliosides. By analogy to diphtheria toxin's action on
elongation factor 2, Michael Gill proposed CTX to act as an
ADP-ribosyl-transferase that covalently modified, in this case a
component of adenylyl cyclase. This component was identified
as the GTP-binding regulatory component in two 1978 papers,
one by Cassel and Pfeuffer, the other by Gill and Meren. (Cassel
and Pfeuffer, 1978 [42]; Gill and Meren, 1978 [43]). Using
[32P-AMP]NAD+ as an [α-32P]ADP-ribose donor, both labora-
tories identified the regulatory component as a 42,000 Da
protein in SDS-PAGE gels. The regulatory component of
adenylyl cyclase purified in 1980 in Gilman's laboratory from
rabbit liver membranes, contained three polypeptides of which
two, one of Mr=45,000, the other of Mr=52,000, were ADP-
ribosylated by cholera toxin; the third, of Mr=35,000, became
the β subunit. The purified protein conferred responsiveness to
hormonal, guanine nucleotide and fluoride stimulation to the
adenylyl cyclase in membranes of the AC− variant of S49 cells,
meanwhile renamed to cyc− S49 cells. Activation of the αβ
dimer by [35S]GTPγS was then shown to involve dissociation
into α-[35S]GTPγS+β, and the α-GTPγS to be the bearer of
the adenylyl cyclase stimulating activity (Northup et al., 1983a
[44]; 1983b [45]).
Although by 1981 it was well known that adenylyl cyclases
were under dual stimulatory and inhibitory control by hormones
and that both types of regulation required GTP, the mechanism
by which inhibition came about was not clear. Was there a
second, inhibitory regulatory component or might inhibitory
hormones act on the equivalent of a GTPase-activating protein,
a GAP, that reduced the activity of the same process that
stimulated activity? The answer to this dilemma came from
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mechanism by which vaccination against whooping cough with
the attenuated etiologic agent of whooping cough, Bordetella
pertussis, sporadically elicited severe hypoglycemic responses,
sometimes causing death by convulsions. Michio Ui's studies
led him to conclude that pertussis vaccines sometimes came
with a residual amount of toxin which provoked massive insulin
release with attendant hypoglycemic convulsions, and that the
toxin worked by a mechanism not unlike that of phentolamine,
an α-adrenergic receptor blocker, which, when infused in
humans with elevated adrenaline levels, suppressed an
inhibitory α2-adrenergic regulation that is part of the normal
control of insulin secretion (Porte, 1967 [46]). Ui and
collaborators referred to the toxin, now pertussis toxin or
PTX, as “islet activating protein” or IAP. They purified it to
homogeneity and determined its subunit composition to be of
the A1B5 type (published in 1982: Tanura et al., 1982 [47]; Fig.
14). With his student Toshiaki Katada, Ui then showed that IAP
reversed inhibitory effects of epinephrine on insulin secretion
from isolated islets and that membrane adenylyl cyclase from
IAP treated islets had much diminished inhibitory response to
epinephrine acting via an α2-adrenergic- and GTP-dependent
mechanism (Katada and Ui, 1980 [48]; 1981 [49]). These
authors also showed that IAP was an ADP-ribosyl transferase
labeling a membrane protein of Mr=40,000 (Katada and Ui,
1982 [50]).
Katatda and Ui's discovery that IAP ADP-ribosylated a
distinct 40 kDa protein (Katada and Ui, 1982 [50]), was a key
finding that clarified in my mind the mechanisms by which
adenylyl cyclase was inhibited by hormones. Hormones
inhibited adenylyl cyclase using a GTP-dependent mechanism
and IAP had been shown to inhibit negative regulation of
adenylyl cyclases. There had to be a Gi! In my laboratory at
Baylor College of Medicine in Houston, I had also been
working on the purification of the regulatory component of
adenylyl cyclase with the help of three postdoctoral fellows:
Juan Codina, John Hildebrandt and Ravi Iyengar. We used the
general scheme published by Gilman's laboratory for the
purification of rabbit liver Gs, with the exception that we did notFig. 14. Sructural features of cholera and pertussis toxins. The ADP-
ribosyltransferase activity of the A1 (CTX) and S1 (PTX) subunits requires
reduction of disulfide bonds by cytosolic glutathione.stabilize the system with Mg2+- and fluoride-containing buffers,
and started from human erythrocytes instead of rabbit liver
membranes. At the time of Katada's and Ui's publication of the
ADP-ribosylation of a 40 kDa protein, we had been staring at an
almost pure preparation of Gs (then called Ns by us), which in
SDS-PAGE gels had the requisite 42 and 35 kDa bands (human
erythrocytes do not have the 52 kDa band), but also an
additional 40 kDa band, that by hydroxylapatite chromatogra-
phy (the last step in Gilman’s purification scheme) was resolved
into two fractions, each containing two bands. One fraction had
bands of 42 and 35 kDa (Gs), the other fraction had bands of
40k and 35 kDa (??) by hydroxylapatite chromatography, the
last step in Gliman's purification scheme. Independently, John
Hildebrandt had established that cyc− membrane adenylyl
cyclase, while unresponsive to stimulation by fluoride, was
under inhibitory regulation by fluoride — present also in wild
type S49 cell membranes.
IAP was not commercially available. I wrote to Ui asking for
IAP to test for presence of the 40 kDa protein in cyc−
membranes. If he sent it, we would also test the purified
fractions for presence of a PTX substrate— possibly the 40 kDa
band between the 42 and 35 kDa bands?3. To improve our
chances in obtaining the toxin, Ravi Iyengar sent a separate
letter to the pharmaceutical company that had purified IAP for
Ui. Ui responded that the protein was not pure enough for
distribution and that he would be pleased to send IAP to
qualified investigators such as me, once he was satisfied with
the product. And, he added, his letter should also be taken as an
answer to Ravi's letter to his collaborator in the pharmaceutical
company. I next got in touch with Jan Wolff, at the NIH, who
had reported at a meeting that he had tested the effect of PTX on
inhibitory regulation of TSH-stimulated adenylyl cyclase in
thyroid membranes. PTX was more precious than gold and
platinum, and he could not give me any. His source had been
Richard Manclark, from the FDA laboratories on the NIH
campus in Bethesda. I received no reply to my letter to
Manclark. I thus, made an appointment to visit him in Bethesda,
and flew from Houston with 15 test tubes into which John
Hildebrandt had aliquoted wild type and cyc− S49 cell
membranes and samples of the Gs purification before and
after the hydroxylapatite step, together with reagents for ADP-
ribosylation including [32P]NAD+, ready to incubate with the
toxin. I left the rack with the pipetted tubes on ice in a styrofoam
container, on the floor outside of Manclark's office, before
entering to talk him into collaborating. Richard Manclark turned
out to be a pleasant man. He had with him a young collaborator,
Ron Sekura, who purified PTX in his laboratory and had
worked on the A1B5 subunit makeup of the toxin. At one point
Ron said “what we should do, is to see if we can ADP-ribosylate
cyc− membranes.” To which I replied “Funny you should say3 We had purified Gs, then Ns, without using fluoride as a stabilizing agent.
Gilman's group stabilized Gs, then G/F, with aluminum fluoride and Mg
(AMF) in their buffers. Without knowing, AMF had caused Gi, but not Gs, to
dissociate at cold room temperatures into αi[Al4F
−]-GDP plus βγ. This caused
the Dallas group to “loose” Gi during their initial purification of Gs. Our Gi
stayed as a trimer. By chance, we had co-purified Gi with Gs — which have
very similar biochemical fractionation behaviors.
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PTX to the tubes, incubated and then froze the tubes. I flew back
to Houston, the styrofoam container, now with dry ice, in the
cabin in the overhead compartment. John Hildebrandt,
precipitated the proteins, took them up into sample buffer and
subjected them to SDS-PAGE. He dried the gel, and exposed it
to an X-ray film. The very first film we got, we sent to our new
collaborators in Bethesda. It showed that cyc− membranes –
which lacked cholera toxin substrate – had the 40 kDa PTX
substrate, and that the 40 kDa band that had co-purified with Gs
was a PTX substrate. If Gs was an αβ dimer, Gi (then Ni) also
had to be an αβ dimer. We published that stimulation and
inhibition of adenylyl cyclase were mediated by distinct
proteins in Nature (Hildebrandt et al., 1983 [51]), and I asked
Ed Krebs in Seattle to communicate our identification of Ni as
an αβ dimer to the Proceedings of the National Academy of
Sciences. We thought that we had caught up with Al Gilman,
who had dominated adenylyl cyclase research field since the
late 70 s, and were going to beat him. Fat chance, while I tried to
get some IAP from Michio Ui, he had recruited Toshiaki
Katada, Ui's student, to work on the purification of the IAP
substrate and had an unlimited supply of IAP. Ed Krebs
forwarded our paper to the Proceedings office on March 12,
1983 (Codina at al., 1983 [52]). Katada and Gilman's paper
came out in print in the February 28, 1983, issue of the J. Biol.
Chem., 5 months ahead of ours (Bokoch et al., 1983 [53]).
7. Paths leading to the discovery and identification of the
light activated GTPase as a signal transducing G protein:
visual signal transduction
In 1971, upon measuring adenylyl cyclase activity in light
and dark adapted retinas, Mark Bitensky, then at Yale, made the
interesting and important observation that the activity in dark
adapted retinas was ca. 10-fold higher than in retinas prepared
under normal illumination or in dark adapted retinas illuminated
prior to the adenylyl cyclase assay. (Bitensky et al., 1971 [54];
Miller et al., 1971 [55]; Bitensky et al., 1972 [56]). He also
found that the activity in dark adapted retinas could be inhibited
by light also in homogenates, but required the integrity of the
rod outer segment (ROS) discs known to carry the visual
pigment rhodopsin responsible for initiating the visual signal
transduction process. Light-induced inhibition of adenylyl
cyclase activity was not observed in homogenate of cone
photoreceptor cells, which are not organized in discs but in
stacked plasma membrane infoldings, and was lost upon
disruption of the rod cell discs with digitonin. Importantly,
light induced inhibition of disc adenylyl cyclase under cell-free
conditions required addition of ATP or GTP, with GTP being ca.
1000-fold more potent than ATP.
By curious coincidence it turned out that, as I had done when
looking for an effect of insulin by measuring adenylyl cyclase
instead of phosphodiesterase (PDE), also Bitensky was focusing
on the wrong enzyme, because light and its transduction
mechanism does not operate on adenylyl cyclase, but on a soon
to be discovered ROS PDE. It is to Mark's credit that he
discovered his own error, which became clear when he testedfor the linearity of cAMP accumulation as a function of time in
dark (high activity) and light (low activity) adapted retinas.
While accumulation of cAMP was linear with time in
homogenates of dark adapted retinas, in illuminated retinas,
90 +% of the cAMP that was being formed was being
hydrolyzed by a very potent light activated PDE (Miki et al.,
1973 [57]). Direct PDE assays of homogenized retinas showed
the enzyme to be activated by light in an ATP or GTP dependent
manner, by the same light spectrum that is absorbed by
rhodopsin. At physiological cyclic nucleotide concentrations,
the retinal PDE preferred cGMP over cAMP by a ratio of 10:1
(Miki et al., 1973 [57]) and was thus different from the then well
known brain PDE. Photoreceptor PDE also differed from the
brain enzyme in that it was insensitive to a calcium dependent
regulator (CDR, now calmodulin). The ROS PDE was found to
be tightly bound to bleached rod discs in the presence of Mg2+,
but to be released upon Mg2+ removal in low ionic strength
buffer. Differential extraction allowed the enzyme to be easily
purified to homogeneity. Although, the pure photoreceptor
PDE, (an αβ heterodimer), was no longer activated by light
(Miki et al., 1975 [58]), it could be activated if mixed with as
little as 2% bleached ROS discs. Photoactivation of rhodopsin
was then shown to generate an activator, that could be detected
in the purified PDE assay (Keirns et al., 1975 [59]). This
activator was heat labile, inactivated by p-chloromercuribenzo-
ate, and resistant to mild trypsin and phospholipase C. Its
activity required GTP and it hydrolyzed GTP. It was a light
activated GTPase (Wheeler et al, 1977 [60]; Wheeler and
Bitensky, 1977 [61]).
Addition of GTP to discs from which the PDE had been
removed led to separation of the light activated GTPase from
the disc membranes. In 1979, the light activated GTPase
became the first G protein to be purified. Originally thought to
be an αβ heterodimer with subunits of 41 and 37 kDa
(Godchaux and Zimmerman, 1979 [62]), it was later found to be
a trimer containing in addition a small ca. 10 kDa subunit that
stains poorly with Coomassie blue (Kuhn, 1980 [63]; Baehr et
al., 1981 [64]). In their article on the purification of the light-
activated GTPase, Godchaux and Zimmerman also proposed
bleached membranes (activated rhodopsin) to act as nucleotide
exchangers, as Cassel and Selinger had done for the erythrocyte
adenylyl cyclase-stimulating β-adrenergic receptor (Cassel and
Selinger, 1978 [33]), identifying the GTPase as the target. The
light-activated GTPase could also be released from dark-
adapted discs by washing just with 1 mM EDTA and 1 mM
DTT (Shinozawa et al., 1980 [65]). When applied to a DEAE-
Sepharose column, this preparation could be separated into two
fractions, G and H, neither of which exhibited GTPase activity,
but which when combined hydrolyzed GTP in the presence of
photoactivated ROS discs. The G fraction had the GTP-binding
and PDE-activating activity; the H fraction (now βγ) stood for
helper, since it was required for interaction with rhodopsin in
bleached discs from which PDE and GTPase had been washed
off (Shinozawa et al., 1980 [65]). These and other experiments
(Shinozawa and Bitensky, 1981 [66]; Godchaux and Zimmer-
man, 1979 [62]; Fung et al., 1981 [67]) led Lubert Stryer, to
propose the “flow of information” model of the light-triggered
Fig. 15. Flow of information in a G protein coupled system as deduced in studies
of the light activated rod outer segment cGMP specific phosphodiesterase and
summarized by Stryer and collaborators (From Fung et al., 1981 [67]). T, transducin.
Fig. 17. The double regulatory cycle of a G protein: activation involves GTP
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al., 1981 [67]). In this model, which still stands today, the
GTPase is the transducing molecule that takes the information
from the activated photoreceptor, and, upon binding GTP
acquires PDE-activating activity. The activated PDE then
hydrolyzes cGMP, reducing its concentration to levels belowFig. 16. A, SDS-PAGE analysis of human erythrocyte Gs and Gi proteins
showing αβγ subunit composition. Lanes 1 and 2, molecular weight standards
B, 1984 model of adenylyl cyclase susceptible to both stimulatory and inhibitory
inputs mediated by respective stimulatory (Gs) and inhibitory (Gi) regulatory
components. Each G protein is shown as a heterotrimer and under the control of
a distinct set of receptors responsible for distinct hormonal specificities
exhibited by adenylyl cyclases from different tissues and cells (Adapted from
Hildebrandt et al., 1984 [67]).
binding and subunit dissociation; deactivation involves GTP hydrolysis and
subunit reassociation. (A) In the absence of receptor — at steady state most of
the G protein is in the “resting” GDP state. (B and C) Under control of receptor
— in the presence of hormone, at steady state, the slow step is the hydrolysis of
GTP and α.GTP accumulates. (B) If the HR complex does not dissociate from
βγ-signaling is exclusively though the α.GTP complex; (C) If the HR complex
dissociates from βγ before the GTPase hydrolyzes GTP-signaling will be
through both, α.GTP and the βγ dimer. (From Birnbaumer, 1993 [72]).those required to keep the cGMP-gated cation channel open,
with the ensuing turn-off of the dark current and concomitant
loss of glutamate secreting activity. In due time, set by the kcat
intrinsic to the GTPase molecule, it hydrolyzes the bound GTP.
This deactivates the PDE-activating function, with attendant
accumulation of newly synthesized cGMP and re-activation of
the ligand-gated ion channel. The GTPase, a veritable
transducer of the light signal into an electrical signal, is now
poised to be activated once more by photoactivated rhodopsin.
Aptly, Stryer coined the term “transducin” for the light activated
GTPase, a name which, like the model, also still stands today. It
would later be shown that the visual PDE is an αβγ2
heterotetramer, in which the γ subunits are inhibitory, and
that the mechanism by which the α subunit of transducin
complexed to GTP (Tα.GTP) activates the PDE is by removal
of inhibitory γ subunits from the PDE by formation of Tα.
GTP::γ complexes (Deterre et al., 1988 [68]). Hydrolysis to
GDP releases γ from Tα, which now can reassociate with the
αβ PDE to reform αβγ2, quenching its activity.
8. Gs and Gi are also heterotrimers
Although in retrospect the similarity between the visual and
hormonal signal transduction systems should have been
obvious, to more than one of us it was not. The fact that Gs
and Gi were published to be dimers by both Gilman's group and
769L. Birnbaumer / Biochimica et Biophysica Acta 1768 (2007) 756–771ours is proof that we were not looking at the light activated
GTPase as a homologue of Gs and Gi.
As Gilman and collaborators had done, we also determined
the molecular weight of Gs and Gi. The proteins had been
obtained in a buffer containing the non-ionic detergent Lubrol
PX and determination of the molecular weight of the protein
component of the detergent–protein complex was a complex
process requiring careful determination of sedimentation
coefficients in normal and deuterated water (H2O and D2O)
and several assumptions. G/F was reported by Gilman's
laboratory to have a protein mass of 70 kDa, which fell to
50 kDa upon activation with either a non-hydrolyzable GTP
analogue or NaF, a reflection of the dissociation of αβ into α*
plus β (Sternweis et al., 1981 [69]). Our measurements, by the
same techniques and with the same assumptions, yielded a
protein mass of 95.5 kDa (Codina et al., 1984 [70]). Thinking
that perhaps Gilman's group had lost something during the
purification, we looked carefully at our Coomassie blue stained
gels and noted that we had something running with the dye
front. This turned out to be the γ subunit, present in the Ns (Gs)
and Ni (Gi) preparations, as well as in what we had thought to
be free β (Hildebrandt et al., 1984 [71], Fig. 16A). With the
discovery of the γ subunits we drew the model of hormone-
stimulated adenylyl cyclase shown in Fig. 16B (Hildebrandt et
al., 1984 [71]). Eventually, Gilman's group also found γ at the
dye front of their gels. The differing Mr estimates were simply a
reflection of the wide error intrinsic to the methodology used.
Fig. 17 presents a dynamic view of G proteins incorporating the
receptor-activated GDP–GTP exchange reaction, the subunit
dissociation reaction, the GTPase activity and the re-assembly
of the trimer upon GTP hydrolysis, ready for reactivation by the
receptor. With H denoting hormone or agonist, the reaction
scheme incorporates my bias as to which the likely reaction
products may be when GTP binds to the HR::αβγ. Alternative
dissociation–reassociation paths were discussed earlier (Birn-
baumer, 1993 [72]) and are still under study.
It was while we were doing these analyses of our purified
proteins, that John Hildebrandt in my laboratory raised the
possibility that Gs and Gi might be structurally related to the light
activated GTPase. These thoughts are discussed in his paper
(Hildebrandt et al., 1984 [71]) and join those ofBitensky, whowas
on record since 1978 for having at a Summer ICN-UCLA
symposium, pointed to similarities between the visual-phospho-
diesterase and the hormone-stimulated adenylyl cyclase signal
transduction systems (Shinozawa et al., 1979 [73]).
Molecular cloning, of course, confirmed the structural
similarities among not only the three heterotrimeric G proteins
identified in this article, but among 16 such G proteins with 16
distinct α subunits, all sharing a set of βγ dimers encoded in 5 β
and 12 γ subunit genes, and all activated by a much larger
family of seven transmembrane receptors, now referred to
generically as GPCRs, G protein-coupled receptors, each
catalyzing the activation of its cognate set of G proteins by
promoting the exchange of resident GDP with the activating
ligand, GTP. The many genes and functions of heterotrimeric G
proteins have recently been reviewed (Birnbaumer, 2004 [74];
Wettschureck and Offermanns, 2005 [75]).Acknowledgements
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